Moreover, since CYLD can act as a negative regulator of NF-κB pathways [48], depressed CYLD expression resulted in aberrant activation of NF-κB, thereby inducing HCC cells to express abundantly a neutrophilic chemokine, CXCL5, which can attract a large number of neutrophils [47]. Here, CYLD is linked to hepatocellular carcinoma.